A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies
Status unconfirmed · Phase 2
Conditions studied: Colorectal Neoplasms
In brief
To determine the rate of response and duration of reponse following therapy with Aroplatin in subjects with advanced colorectal cancer resistant to standard therapies. Secondary objectives are to determine safety and tolerability of the Aroplatin therapy.
Key facts
- Study ID
- NCT00043199
- Run by
- Aronex Pharmaceuticals
- People needed
- 40
- Last updated by the study team
- 2005-06-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Colorectal cancer, locally recurrent, unresectable or metastatic disease (AJCC);
- Measurable disease (RECIST criteria);
- Cancer refractory to 5-FU/leucovorin or capecitabine, and irinotecan;
- ECOG performance score of 0-2;
- Adequate hematopoietic, liver and renal function;
- Adequate cardiac function (maximum of class II, NYHA);
- Women of child-bearing potential must have a negative urine or serum pregnancy test;
- Signed written informed consent;
- Subjects must be willing to to be followed during the course of treatment/observation and follow-up.
You may not qualify if…
- Other malignancies treated within the last five years, except in situ cervix carcinoma or non-melanoma skin cancer;
- Pregnant or breast feeding subjects, or male or female subjects of child producing potential who will not agree to use adequate contraception during the treatment phase of the study;
- Prior therapy with oxaliplatin;
- Known brain metastases;
- Active, uncontrolled infection or other serious medical illnesses;
- Subjects may not be using or have used any investigational therapy during four weeks before start of the protocol treatment.
Where it is running
- Arizona Cancer Center — Tucson, Arizona, United States
- University Medical Center — Tucson, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.